# NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

Study · id `cardio:ct-nct01783600` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01783600](<https://clinicaltrials.gov/study/NCT01783600>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01783600

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01783600. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2016-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01783600, source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT01783600, source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)
- Primary completion: 2016-03 (actual) (ClinicalTrials.gov record NCT01783600, source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)
- Completion: 2016-03 (actual) (ClinicalTrials.gov record NCT01783600, source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)
- Countries: Belgium (ClinicalTrials.gov record NCT01783600, source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01783600-2016-08-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions
- Condition: Peripheral Arterial Disease
- Intervention (Device): NanoCross .014 balloon catheter
- Lead sponsor: Flanders Medical Research Program
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Flanders Medical Research Program (`cardio:org-flanders-medical-research-program`)

## Provenance

Content hash: 667209c930d974bc353014d8ad26e6f219120ea577d4392638cff5bee927a401
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
